Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
University of Alberta · Uppsala University · +3 more institutions
Abstract
No abstract available for this paper.
Citation impact
- FWCI
- 71.63
- Percentile
- 100%
- References
- 693
Authors
15- MDMaija DambrovaCorresponding
University of Alberta, Uppsala University, Jena University Hospital, Latvijas Organiskās Sintēzes Institūts
- MMMarina Makrecka‐Kuka
Latvian Academy of Sciences, Latvijas Organiskās Sintēzes Institūts, University of Alberta, Jena University Hospital, Uppsala University
- JKJanis Kuka
Jena University Hospital, Uppsala University, University of Alberta, Latvian Academy of Sciences, Latvijas Organiskās Sintēzes Institūts
- RVReinis Vilšķe̅rsts
University of Alberta, Uppsala University, Latvian Academy of Sciences, Latvijas Organiskās Sintēzes Institūts, Jena University Hospital
- DODidi O. T. Nordberg
Latvijas Organiskās Sintēzes Institūts, Uppsala University, Jena University Hospital, Latvian Academy of Sciences, University of Alberta
Topics & keywords
- Drug
- Nomenclature
- Clinical trial
- Computational biology
- Pharmacology
- Medicine
- Drug trial
- Biology
- Good health and well-being